Brainsway (BWAY) Cash & Current Investments (2018 - 2026)
Brainsway (BWAY) posted quarterly Cash & Current Investments of $59.8 million for Q1 2026, down 16.52% year-on-year from $71.6 million in Q1 2025, and down 13.54% on a QoQ basis from $69.1 million in Q4 2025.
Brainsway (BWAY) Cash & Current Investments (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Cash & Current Investments for 9 consecutive years, with $59.8 million the latest figure, recorded in Q1 2026.
- Quarterly Cash & Current Investments fell 16.52% year-over-year to $59.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.8 million (down 16.52% YoY) and the FY2025 annual result came in at $69.1 million, changed 0.31% from the prior year.
- Cash & Current Investments fell to $59.8 million in Q1 2026 per BWAY's latest filing, from $69.1 million in the prior quarter.
- Over the last five years, Cash & Current Investments for BWAY reached as high as $71.6 million in Q1 2025 and fell as low as $43.4 million in Q2 2023.
- A 5-year average of $55.1 million and a median of $49.6 million in 2022 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments retreated 18.91% — and 2024, when it soared 50.8%.
- Year by year, Cash & Current Investments stood at $47.9 million in 2022, then dropped by 3.9% to $46.0 million in 2023, then soared by 50.8% to $69.3 million in 2024, then retreated by 0.31% to $69.1 million in 2025, then slipped by 13.54% to $59.8 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $59.8 million, $69.1 million, and $71.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Brainsway | 598.04 Mn | 538.27 Mn | 11.68 Mn | 59.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.77 Mn |
| Dec 31, 2025 | 69.13 Mn |
| Sep 30, 2025 | 71.54 Mn |
| Jun 30, 2025 | 68.86 Mn |
| Mar 31, 2025 | 71.60 Mn |
| Dec 31, 2024 | 69.35 Mn |
| Sep 30, 2024 | 48.13 Mn |
| Jun 30, 2024 | 47.86 Mn |
| Mar 31, 2024 | 47.58 Mn |
| Dec 31, 2023 | 45.99 Mn |
| Sep 30, 2023 | 44.16 Mn |
| Jun 30, 2023 | 43.44 Mn |
| Mar 31, 2023 | 44.32 Mn |
| Dec 31, 2022 | 47.85 Mn |
| Sep 30, 2022 | 49.62 Mn |
| Jun 30, 2022 | 52.45 Mn |
| Mar 31, 2022 | 54.66 Mn |
| Dec 31, 2021 | 57.35 Mn |
| Sep 30, 2021 | 55.34 Mn |
| Jun 30, 2021 | 55.87 Mn |